Boston Family Office’s Allergan Inc AGN Stock Holding History

Boston Family Office’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,183	Closed	-$1.74M	–	265
2014 Q4	$1.74M	Sell	8,183 -85	-1%	-$16.9K	0.22%	116
2014 Q3	$1.47M	Sell	8,268 -25	-0.3%	-$4.15K	0.19%	120
2014 Q2	$1.4M	Sell	8,293 -855	-9%	-$133K	0.18%	125
2014 Q1	$1.14M	Hold	9,148	–	–	0.15%	136
2013 Q4	$1.02M	Buy	9,148 +3,900	+74%	+$373K	0.13%	144
2013 Q3	$475K	Buy	5,248 +1,850	+54%	+$166K	0.07%	193
2013 Q2	$286K	Buy	+3,398	New	+$353K	0.04%	225

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boston Family Office's AGN Position: Q1 2015 in Review

Boston Family Office sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 8,183 shares — an estimated $1.74M sold.

Boston Family Office first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.74M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Boston Family Office reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Boston Family Office sold 8,183 Allergan Inc shares in Q1 2015, an estimated $1.74M.
Boston Family Office first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Boston Family Office's Allergan Inc position peaked at $1.74M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Boston Family Office's 13F filing for Q1 2015, filed 11 May 2015.